41 | Trastuzumab (Herceptin)FDA Link
05/2024
-
01/2005 |
28 | Epidermal Growth Factor (EGF)IBA
05/2024
-
12/2002 |
21 | Immunoconjugates (Immunoconjugate)IBA
05/2024
-
03/2006 |
16 | Monoclonal AntibodiesIBA
10/2021
-
05/2006 |
14 | Immunoglobulin G (IgG)IBA
12/2023
-
12/2002 |
14 | Peptides (Polypeptides)IBA
01/2021
-
03/2006 |
13 | GoldIBA
05/2024
-
12/2010 |
13 | Pentetic Acid (DTPA)FDA LinkGeneric
01/2020
-
04/2004 |
12 | Panitumumab (Vectibix)FDA Link
05/2024
-
02/2015 |
11 | ErbB Receptors (EGF Receptor)IBA
10/2022
-
09/2003 |
10 | PolymersIBA
01/2019
-
05/2012 |
10 | Immunoglobulin Fab FragmentsIBA
11/2015
-
01/2005 |
9 | Radioisotopes (Radionuclides)IBA
05/2024
-
05/2005 |
9 | MetalsIBA
01/2019
-
10/2005 |
8 | MicellesIBA
05/2024
-
09/2007 |
8 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2023
-
02/2012 |
8 | RadiopharmaceuticalsIBA
12/2022
-
09/2003 |
8 | Proteins (Proteins, Gene)FDA Link
12/2022
-
04/2004 |
8 | Saline SolutionIBA
10/2022
-
09/2003 |
8 | CreatinineIBA
11/2020
-
09/2003 |
7 | Alanine Transaminase (SGPT)IBA
11/2020
-
09/2003 |
7 | AcidsIBA
12/2016
-
09/2003 |
5 | pertuzumabIBA
01/2021
-
08/2009 |
5 | Chelating AgentsIBA
01/2019
-
10/2005 |
5 | EpitopesIBA
11/2014
-
03/2006 |
4 | Nuclear Localization Signals (Nuclear Localization Signal)IBA
12/2022
-
08/2012 |
4 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2022
-
04/2016 |
4 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2007
-
09/2005 |
3 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
05/2024
-
05/2020 |
3 | neodymium pyrocatechin disulfonate (NPD)IBA
11/2022
-
12/2016 |
3 | AntibodiesIBA
11/2022
-
09/2006 |
3 | His-His-His-His-His-His ((His)6)IBA
01/2021
-
05/2007 |
3 | Ado-Trastuzumab EmtansineIBA
05/2020
-
01/2018 |
3 | nimotuzumabIBA
01/2020
-
08/2012 |
3 | DNA (Deoxyribonucleic Acid)IBA
10/2019
-
03/2009 |
3 | Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
10/2018
-
09/2011 |
3 | StreptavidinIBA
11/2015
-
01/2013 |
3 | LigandsIBA
01/2013
-
09/2007 |
2 | Dendrimers (Dendrons)IBA
05/2024
-
08/2013 |
2 | Liposomes (Liposome)IBA
05/2024
-
11/2017 |
2 | human ERBB2 proteinIBA
11/2015
-
12/2012 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
03/2014
-
03/2010 |
2 | Hormones (Hormone)IBA
01/2013
-
09/2003 |
2 | scyllitol (scyllo-inositol)IBA
10/2011
-
10/2009 |
2 | Hemoglobins (Hemoglobin)IBA
07/2010
-
09/2003 |
2 | hippuryl-glycyl-glycine (HIGG)IBA
07/2010
-
08/2009 |
2 | Methotrexate (Mexate)FDA LinkGeneric
03/2010
-
09/2008 |
2 | Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2009
-
09/2006 |
2 | 111In-DTPA-human epidermal growth factorIBA
08/2008
-
06/2006 |
2 | Messenger RNA (mRNA)IBA
02/2008
-
09/2003 |
2 | Tumor Viral Antigens (Large T Antigen)IBA
08/2007
-
05/2006 |
2 | Cyclin-Dependent Kinase Inhibitor p21IBA
03/2007
-
09/2006 |
2 | tat Gene Products (tat Protein)IBA
01/2007
-
09/2006 |
2 | WK-X-34IBA
11/2006
-
07/2006 |
1 | CelluloseIBA
05/2024 |
1 | Carbon Nanotubes (Carbon Nanotube)IBA
05/2024 |
1 | Growth Factor ReceptorsIBA
12/2023 |
1 | EndotoxinsIBA
12/2022 |
1 | Therapeutic UsesIBA
11/2022 |
1 | POEGMAIBA
01/2022 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2020 |
1 | rucaparibIBA
05/2020 |
1 | GemcitabineFDA Link
05/2020 |
1 | SuspensionsIBA
10/2017 |
1 | AntigensIBA
01/2017 |
1 | Indicators and Reagents (Reagents)IBA
01/2015 |
1 | CSL360IBA
11/2014 |
1 | 2- (1- hydroxyundecyl)- 1- (4- nitrophenylamino)- 6- phenyl- 6,7a- dihydro- 1H- pyrrolo(3,4- b)pyridine- 5,7(2H,4aH)- dioneIBA
05/2014 |
1 | Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA
05/2014 |
1 | Phosphoric Monoester Hydrolases (Phosphatases)IBA
05/2014 |
1 | ChromatinIBA
03/2014 |
1 | butyl phosphorotrithioate (DEF)IBA
11/2013 |